Sierra Ocean LLC Takes $26,000 Position in Haleon plc (NYSE:HLN)

Sierra Ocean LLC acquired a new stake in Haleon plc (NYSE:HLNFree Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 2,775 shares of the company’s stock, valued at approximately $26,000.

Several other large investors have also modified their holdings of HLN. CWM LLC boosted its holdings in shares of Haleon by 13.6% in the third quarter. CWM LLC now owns 24,978 shares of the company’s stock valued at $264,000 after acquiring an additional 2,996 shares during the period. Creative Planning boosted its holdings in shares of Haleon by 15.2% in the third quarter. Creative Planning now owns 285,227 shares of the company’s stock valued at $3,018,000 after acquiring an additional 37,566 shares during the period. Bleakley Financial Group LLC acquired a new stake in shares of Haleon in the third quarter valued at approximately $126,000. Blue Trust Inc. boosted its holdings in shares of Haleon by 62.4% in the third quarter. Blue Trust Inc. now owns 40,173 shares of the company’s stock valued at $425,000 after acquiring an additional 15,439 shares during the period. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of Haleon by 44.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 25,560 shares of the company’s stock valued at $270,000 after acquiring an additional 7,856 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

HLN has been the subject of several recent research reports. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Haleon has a consensus rating of “Moderate Buy” and an average price target of $10.95.

View Our Latest Stock Analysis on HLN

Haleon Price Performance

Shares of NYSE HLN opened at $9.98 on Wednesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The stock has a fifty day moving average price of $9.55 and a 200 day moving average price of $9.81. Haleon plc has a 1-year low of $7.89 and a 1-year high of $10.80. The company has a market cap of $45.15 billion, a PE ratio of 29.34, a P/E/G ratio of 2.70 and a beta of 0.28.

Haleon Company Profile

(Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Recommended Stories

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLNFree Report).

Institutional Ownership by Quarter for Haleon (NYSE:HLN)

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.